Vitreoretinal Disease – Comprehensive Medical Guide

Overview

Vitreoretinal disease refers to any disorder that affects the **vitreous body** (the clear gel that fills the eye) and the **retina** (the light‑sensitive tissue at the back of the eye). The retina converts light into electrical signals that the brain interprets as vision; the vitreous helps keep the retina in place and provides a clear optical pathway. When these structures are damaged, vision can become distorted, blurred, or lost.

These conditions are most common in adults over 50, but some forms (e.g., retinal detachment after trauma) can occur at any age. In the United States, retinal disorders affect roughly **1 in 10 adults** over 40, and vitreous‑related problems (such as posterior vitreous detachment) occur in **up to 30 % of people aged 65‑74**.¹

Symptoms

Because the vitreous and retina are essential for sharp vision, a wide range of symptoms may arise. Not every symptom means a serious disease, but any new change in vision warrants prompt evaluation.

• Floaters – Small, dark specks or cobweb‑like shapes that drift across the visual field.
• Flashes of light (photopsia) – Brief, bright streaks especially noticed in peripheral vision.
• Blurred or distorted vision – Straight lines may appear wavy (metamorphopsia).
• Reduced central vision – Difficulty reading, recognizing faces, or performing fine tasks.
• Loss of peripheral vision – “Tunnel vision” or a dark shadow moving across the field.
• Dark spots or curtain‑like shadows – Often a sign of retinal tear or detachment.
• Eye pain or pressure – May accompany inflammation (e.g., uveitis) or intra‑ocular hemorrhage.
• Color vision changes – Colors may appear faded or altered.
• Increased sensitivity to glare – Bright lights become uncomfortable.

Causes and Risk Factors

Primary Causes

• Posterior Vitreous Detachment (PVD) – The vitreous gel shrinks with age and pulls away from the retina, sometimes tearing it.
• Retinal Tears or Breaks – Result from traction during PVD, trauma, or high myopia.
• Retinal Detachment – Fluid seeps through a retinal break, separating the retina from underlying tissue.
• Diabetic Retinopathy – Chronic hyperglycemia damages retinal blood vessels, leading to leakage, neovascularisation, and vitreous hemorrhage.
• Age‑Related Macular Degeneration (AMD) – Degeneration of the macula can be complicated by choroidal neovascularisation affecting the vitreoretinal interface.
• Retinal Vascular Occlusions – Blockage of retinal arteries or veins can cause ischemia and subsequent vitreoretinal disease.
• Inflammatory Conditions – Uveitis, sarcoidosis, or infectious retinitis (e.g., toxoplasmosis) may affect the vitreoretinal interface.
• Trauma – Blunt or penetrating eye injury can cause vitreous haemorrhage, retinal tears, or detachment.

Risk Factors

• Age > 50 years (natural vitreous degeneration)
• High myopia (≥‑6.00 D) – elongated eyeball stretches retina
• Diabetes mellitus – especially uncontrolled or long‑standing disease
• Family history of retinal detachment or AMD
• Previous eye surgery (cataract extraction, vitrectomy)
• Severe eye trauma or previous retinal tears
• Use of corticosteroids (systemic or intra‑ocular) – can promote neovascularisation
• Smoking – doubles risk of AMD and impairs retinal blood flow²

Diagnosis

Early detection is crucial. Eye care professionals use a combination of history, slit‑lamp examination, and imaging.

Clinical Examination

• Visual acuity testing – Determines the level of vision loss.
• Dilated fundus examination – Allows direct view of the retina and vitreous using ophthalmoscopy.
• Intra‑ocular pressure measurement – Excludes glaucoma, which can coexist.

Imaging & Specialized Tests

• Optical Coherence Tomography (OCT) – Cross‑sectional images of retina and vitreous; essential for macular disease, epiretinal membranes, and cystoid edema.
• Fundus Photography – Baseline documentation of retinal lesions.
• Fluorescein Angiography (FA) – Highlights retinal blood‑vessel leakage, neovascularisation, and areas of non‑perfusion.
• Indocyanine Green Angiography (ICG) – Better visualises choroidal vessels, useful in AMD.
• Ultrasound B‑scan – Detects retinal detachment or vitreous hemorrhage when media are opaque.
• Wide‑field imaging – Captures peripheral retina, improving detection of tears or detachments.

Treatment Options

Treatment is tailored to the specific vitreoretinal condition, its severity, and the patient’s overall health.

Medications

• Anti‑VEGF agents (e.g., ranibizumab, aflibercept, bevacizumab) – Inhibit new blood‑vessel growth in diabetic retinopathy and AMD. Administered by intravitreal injection every 4‑8 weeks.
• Corticosteroid implants (e.g., dexamethasone Ozurdex) – Reduce macular edema from retinal vein occlusion or uveitis.
• Systemic antibiotics/antivirals – Required for infectious retinitis (e.g., toxoplasmosis, herpes simplex).
• Oral or intravitreal anti‑inflammatory drugs – For uveitic vitreoretinal disease.

Procedures & Surgeries

• Laser Photocoagulation – Burns peripheral retina to seal retinal tears or treat proliferative diabetic retinopathy.
• Pneumatic retinopexy – Gas bubble injected into vitreous to push a detached retina back against the wall; combined with laser.
• Scleral buckle surgery – Silicone band placed around the eye to indent the wall and close retinal breaks.
• Pars Plana Vitrectomy (PPV) – Removal of the vitreous gel, used for vitreous hemorrhage, epiretinal membrane, macular hole, or complex retinal detachments.
• Macular hole surgery – PPV with internal limiting membrane (ILM) peel and gas tamponade.
• Retinal implant or prosthesis (experimental) – For end‑stage retinal degeneration.

Lifestyle & Supportive Measures

• Control systemic diseases: tight glycaemic control (A1C < 7 %), blood pressure < 130/80 mm Hg, and lipid management.
• Quit smoking and limit alcohol consumption.
• Protect eyes from trauma: safety glasses during sports or high‑risk work.
• Regular follow‑up appointments (typically every 3‑12 months depending on disease activity).

Living with Vitreoretinal Disease

Adapting daily life can preserve vision and quality of life.

• Vision rehabilitation – Low‑vision aids (magnifiers, high‑contrast reading lights, electronic reading devices).
• Environmental modifications – Improved lighting, reduced glare, contrasting colors on stairs and countertops.
• Assistive technology – Screen‑reading software, voice‑activated assistants, smartphone accessibility settings.
• Regular eye examinations – Adhere to the schedule set by your retina specialist; many conditions progress silently.
• Medication adherence – Keep a log for intravitreal injection dates or oral meds; use reminders.
• Psychological support – Vision loss can cause anxiety or depression; consider counseling or support groups.
• Driving considerations – Self‑assess visual fields; discuss fitness to drive with your ophthalmologist.

Prevention

While some vitreoretinal problems (e.g., PVD) are age‑related and unavoidable, many risk factors are modifiable.

• Maintain healthy blood glucose – Regular monitoring, medication, diet, and exercise.
• Control blood pressure and cholesterol – Reduces risk of retinal vascular occlusions.
• Protect eyes from UV and blue light – Wear sunglasses with 99‑% UV protection; consider blue‑light filters for digital devices.
• Use protective eyewear during high‑risk activities (sports, construction).
• Quit smoking – Discuss nicotine‑replacement or pharmacotherapy with a healthcare provider.
• Screen for diabetic retinopathy – Annual dilated exams for all patients with diabetes, per ADA guidelines.³
• Nutrition – Diet rich in omega‑3 fatty acids, lutein, zeaxanthin, and antioxidants may protect retinal health.

Complications

If left untreated, vitreoretinal disease can lead to permanent vision loss and systemic consequences.

• Permanent visual field loss – From retinal detachment or extensive macular damage.
• Proliferative vitreoretinopathy (PVR) – Scar tissue formation after retinal detachment surgery, making re‑attachment harder.
• Neovascular glaucoma – Abnormal vessels grow in the anterior chamber, elevating intra‑ocular pressure.
• Choroidal neovascularisation – In AMD, can cause rapid central vision loss.
• Vitreous hemorrhage – Can obscure vision for weeks and increase the risk of retinal tears.
• Psychosocial impact – Reduced independence, higher risk of falls, depression.

When to Seek Emergency Care

References

1. Centers for Disease Control and Prevention. Vision Health Statistics. 2023. https://www.cdc.gov/visionhealth/resources/statistics.htm
2. World Health Organization. Tobacco and Vision Loss. 2022. https://www.who.int/news-room/fact-sheets/detail/tobacco
3. American Diabetes Association. Standards of Care in Diabetes—2024. Diabetes Care. 2024;47(Suppl 1). https://www.diabetes.org/diabetes/vision/eye-exams
4. Mayo Clinic. Retinal detachment. Updated 2023. https://www.mayoclinic.org/diseases-conditions/retinal-detachment/symptoms-causes/syc-20356089
5. Cleveland Clinic. Vitreoretinal Diseases: Diagnosis and Treatment. 2022. https://my.clevelandclinic.org/health/diseases/21586-vitreo-retinal-diseases